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Abstract. 
 
Furin and TGN38 are membrane proteins 
that cycle between the plasma membrane and the trans-
Golgi network (TGN), each maintaining a predominant 
distribution in the TGN. We have used chimeric pro-
teins with an extracellular Tac domain and the cytoplas-
mic domain of TGN38 or furin to study the trafﬁcking 
of these proteins in endosomes. Previously, we demon-
strated that the postendocytic trafﬁcking of Tac-TGN38 
to the TGN is via the endocytic recycling pathway 
(Ghosh, R.N., W.G. Mallet, T.T. Soe, T.E. McGraw, and 
F.R. Maxﬁeld. 1998. 
 
J. Cell Biol.
 
 142:923–936). Here we 
show that internalized Tac-furin is delivered to the 
TGN through late endosomes, bypassing the endocytic 
recycling compartment. The transport of Tac-furin from 
late endosomes to the TGN appears to proceed via an 
efﬁcient, single-pass mechanism. Delivery of Tac-furin 
but not Tac-TGN38 to the TGN is blocked by nocoda-
zole, and the two pathways are also differentially af-
fected by wortmannin. These studies demonstrate the 
existence of two independent pathways for endosomal 
transport of proteins to the TGN from the plasma 
membrane.
Key words: endocytosis • endosomes • Golgi complex 
• protease • transport
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 internalization from the plasma membrane,
most solutes, ligands, lipids, and transmembrane
proteins enter compartments known as sorting
endosomes (Mukherjee et al., 1997). From these endo-
somes, the predominant pathways transport most mem-
brane proteins and lipids back to the cell surface, whereas
soluble species are delivered to late endosomes and lyso-
somes (Gruenberg and Maxfield, 1995). However, some
transmembrane proteins escape the endocytic recycling
pathway and are delivered to other intracellular or-
ganelles. Among these is a subset of proteins that are tar-
geted to the TGN, including the cation-independent man-
nose 6-phosphate/insulin-like growth factor II receptor
(CI-MPR)
 
1
 
 (Duncan and Kornfeld, 1988; Jin et al., 1989),
metallocarboxypeptidase D (Varlamov and Fricker, 1998),
peptidylglycine 
 
a
 
-amidating monooxygenase (Milgram et al.,
1993), furin (Bosshart et al., 1994; Molloy et al., 1994;
Schäfer et al., 1995; Takahashi et al., 1995), and TGN38
(Ladinsky and Howell, 1992; Bos et al., 1993; Reaves et al.,
1993). Each of these proteins exhibits a high degree of en-
richment in the TGN, in contrast to recycling proteins such
as the transferrin receptor which are delivered to the TGN
only very inefficiently (Snider and Rogers, 1985; Green
and Kelly, 1992).
Endocytic recycling of membrane proteins, such as
transferrin receptors in CHO cells, does not require spe-
cific sorting motifs (Mayor et al., 1993), and membrane
proteins lacking cytoplasmic domains are recycled effi-
ciently (Jing et al., 1990). Under various other circum-
stances, positive sorting of membrane proteins is required,
as for the polarized delivery of membrane proteins to
plasma membrane domains of epithelial cells (Matter et al.,
1993; Mostov and Cardone, 1995) or the transport of cer-
tain receptors to degradative compartments (Miller et al.,
1986). The latter postendocytic fate must result from a
specific property of the membrane protein, possibly in-
volving active sorting and removal of the protein from the
recycling pathway. Sorting out of the recycling pathway
may occur at multiple steps. For example, a transmem-
brane protein may be retained in the sorting endosome as
it matures into a late endosome (Salzman and Maxfield,
1988; Dunn and Maxfield, 1992), thereby preventing deliv-
ery to the endocytic recycling compartment (ERC). From
the late endosome, such a protein could then be trans-
ported to the TGN or to a lysosome. Transport from the
plasma membrane to the TGN via late endosomes has
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been proposed for the CI-MPR (Dahms et al., 1989), al-
though this has not been directly demonstrated. Alterna-
tively, a membrane protein may enter the recycling com-
partment, but then be delivered to the TGN rather than
recycling to the plasma membrane. The existence of this
pathway is supported by the detection of the small GTP-
ase Rab11 on both the recycling compartment and the
TGN (Úrbe et al., 1993; Ullrich et al., 1996) and by the
close spatial apposition of the two compartments in many
cell types (Hopkins and Trowbridge, 1983; Yamashiro et
al., 1984; Lippincott-Schwartz et al., 1991). It is also possi-
ble that a pathway directly links sorting endosomes to the
TGN, whereby a transmembrane protein could enter the
TGN without passing through late endosomes or the ERC.
Each pathway may exist in cells, and the exact route fol-
lowed would then depend on the transmembrane protein
itself.
We described recently the transport of a chimeric trans-
membrane protein, Tac-TGN38, to the TGN of CHO-
derived TRVb-1 cells via the endocytic recycling pathway
(Ghosh et al., 1998). This protein is delivered to the TGN
by iterative removal from the recycling pathway, recycling
multiple times on average before reaching the TGN. Im-
portantly, Tac-TGN38 appears to bypass late endosomes
entirely, and we have proposed instead that it is delivered
from the recycling compartment itself to the TGN. A very
similar trafficking itinerary was reported for the Shiga
toxin B-fragment (Mallard et al., 1998). To determine if
other membrane proteins use this pathway to reach the
TGN from the plasma membrane, we have expressed an-
other chimeric protein, Tac-furin, in TRVb-1 cells. The
Tac-furin chimera incorporates the cytoplasmic domain of
furin, which comprises the rapid internalization and TGN
targeting sequences, with the transmembrane and lumenal
domains of the Tac antigen (Bosshart et al., 1994). This ar-
chitecture allows us to determine the postendocytic trans-
port route of the chimera by detecting internalized anti-
Tac antibodies at various stages of transport. We find that,
in contrast to Tac-TGN38, Tac-furin does not enter the en-
docytic recycling pathway. Rather, the protein is delivered
to the TGN via late endosomes. Consistent with these two
distinct endocytic routes to the TGN, delivery of internal-
ized Tac-furin to the TGN was inhibited by nocodazole,
which did not significantly alter Tac-TGN38 transport.
Also, Tac-furin accumulated in late endosomes in the
presence of wortmannin, whereas Tac-TGN38 was re-
moved slowly from the recycling pathway and delivered to
the TGN. Finally, whereas Tac-TGN38 is delivered to the
TGN by iterative sorting over multiple passes through the
recycling pathway, Tac-furin is transported to the TGN via
a single pass through late endosomes. We have therefore
characterized two independent pathways from endosomes
to the TGN.
 
Materials and Methods
 
Cells and Constructs
 
Chimeric Tac-furin protein constructs TTF and TFF in the plasmid
pCDM8.1 incorporating the cytomegalovirus promoter were obtained
from Michael Marks (University of Pennsylvania, Philadelphia, PA)
(Bosshart et al., 1994), and Juan Bonifacino (National Institutes of Health,
Bethesda, MD) (Wolins et al., 1997). TRVb-1 cells are a CHO cell line
 
which lacks endogenous transferrin receptors but stably expresses the hu-
man transferrin receptor (McGraw et al., 1987). TRVb-1 cells were
cotransfected with the Tac-furin plasmids and the pMEP plasmid (encod-
ing resistance to hygromycin) using the LipofectAMINE reagent system
(GIBCO BRL). Cells expressing Tac-furin constructs were selected by
culturing in 200 U/ml hygromycin. Clonal populations of the TTF and
TFF expressing cells were isolated for quantitative analyses. TRVb-1/Tac-
TGN38 cells were described previously (Ghosh et al., 1998). TRVb-1 cells
expressing Tac-furin chimeras or Tac-TGN38 were propagated as de-
scribed previously (Ghosh et al., 1998), except that TRVb-1/Tac-furin cells
were grown in the presence of 200 U/ml hygromycin.
 
Antibodies and Fluorescent Reagents
 
Monoclonal antibodies (IgG1) against Tac were purified from ascites fluid
prepared from the hybridoma cell line 2A3A1H (ATCC) using protein G
affinity chromatography. Antibodies were conjugated to Cy3 (Cy3–anti-
Tac) (Amersham North America), Alexa 488 (A488–anti-Tac) (Molecu-
lar Probes), or fluorescein isothiocyanate (FITC–anti-Tac) (Molecular
Probes) according to the manufacturers’ instructions. For some experi-
ments, antibodies were labeled with Na
 
125
 
I as described previously (Ya-
mashiro et al., 1984). Low density lipoproteins (LDLs) labeled with DiI
were prepared as described (Pitas et al., 1981). Human apotransferrin
(Sigma Chemical Co.) was iron-loaded as described previously (Yama-
shiro et al., 1984) and conjugated to Cy3, Cy5 (Amersham), or Alexa 488 ac-
cording to the manufacturers’ instructions. NBD-C
 
6
 
-ceramide [N-(
 
e
 
-7-ni-
trobenz-2-oxa-1,3-diazol-4-yl-aminocaproyl)-
 
D
 
-erythro-sphingosine] and
fixable 70-kD dextrans conjugated to rhodamine were purchased from
Molecular Probes. Polyclonal antibodies against the cytoplasmic domain
of rat TGN38 were obtained from Keith Stanley (Heart Research In-
stitute, Sydney, Australia) (Luzio et al., 1990) or from George Banting
(University of Bristol, Bristol, United Kingdom) (Wilde et al., 1992). Poly-
clonal antibodies against a conserved peptide sequence (TQMNDN-
RHGTRC) in the furin enzymatic site were obtained from Yukio Ikehara
(Fukuoka University, Fukuoka, Japan) (Misumi et al., 1991). Polyclonal
antibodies against the CI-MPR were obtained from Peter Lobel (Robert
Wood Johnson Medical School, Piscataway, NJ) (Chen et al., 1993). Poly-
clonal antibodies against fluorescein were purchased from Molecular
Probes. Fluorescently labeled polyclonal antibodies against rabbit immu-
noglobulins were purchased from Sigma Chemical Co., Jackson Immu-
noResearch, or Pierce Chemical Co.
 
Fluorescence Staining Methods
 
For microscopy, cells were passaged onto poly-
 
D
 
-lysine–treated Number 1
coverslips affixed beneath holes cut into the bottoms of 35-mm Petri
dishes. For incubations of live cells with antibodies or ligands, cells were
treated as described previously (Ghosh et al., 1998), except as indicated.
For indirect immunofluorescence labeling, fixed cells were permeabilized
with 0.01% (wt/vol) saponin (Sigma Chemical Co.) in Medium 1 (150 mM
NaCl, 20 mM Hepes, 1 mM CaCl
 
2
 
, 5 mM KCl, 1 mM MgCl
 
2
 
, pH 7.4) with
0.5% BSA (AB buffer). Antibodies were diluted into AB buffer for appli-
cation to cells, and all washes were with AB buffer. Labeling with NBD-
C
 
6
 
-ceramide (Pagano et al., 1989) was performed as described (Ghosh et al.,
1998).
 
Microscopy
 
Digital epifluorescence microscopy (see Figs. 3, 4 D, and 5, E and F) was
performed as described previously (Ghosh et al., 1998). Confocal micros-
copy was performed using an MRC600 laser scanning unit (BioRad) and
an Axiovert 35 microscope (Carl Zeiss) with a 63
 
3
 
 1.4 NA plan Apochro-
mat objective (Zeiss) (see Figs. 4, 6, and 7), or an LSM 510 laser scanning
unit (Zeiss) and an Axiovert 100M inverted microscope (Zeiss) with a
63
 
3
 
 1.4 NA plan Apochromat objective (Zeiss) (see Figs. 1, 2, 5, A–D, 8,
and 9). Excitation on the MRC600 unit was with a 25-mW argon ion laser
emitting at 488 nm and 514 nm, and emissions were collected using stan-
dard fluorescein and rhodamine filter sets. Excitation on the LSM 510 unit
was with a 25-mW argon laser emitting at 488 nm, a 1.0-mW helium/neon
laser emitting at 543 nm, and a 5.0-mW helium/neon laser emitting at
633 nm; emissions were collected using a 505–530-nm band pass filter to
collect fluorescein and Alexa 488 emissions and a 585-nm long pass filter
to collect rhodamine, Cy3, and DiI emissions. For Fig. 5, Cy3 emissions
were collected with a 560–615-nm band pass filter, and Cy5 emissions
were collected with a 650-nm long pass filter. Typically, 0.5-
 
m
 
m vertical
steps were used, with a vertical optical resolution of 
 
,
 
1.0 
 
m
 
m. 
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Kinetic Experiments
 
To determine the rate of Tac-furin externalization by accumulation of flu-
orescent antibodies, TRVb-1/Tac-furin cells cultured on coverslips were
incubated with Cy3–anti-Tac IgG (3 
 
m
 
g/ml) in McCoy’s 5A 
 
1
 
 0.1% BSA
for 5, 10, 15, 20, 30, 40, 50, 60, 75, or 90 min. Unbound antibody was re-
moved by washing, and cells were fixed. Cy3 fluorescence was imaged by
epifluorescence microscopy. Fluorescence power per cell was determined
as described below. Fluorescence power was relatively uniform among all
cells for each time point.
Determination of the externalization rate by accumulation of radiola-
beled antibodies, measurement of the level of surface expression of Tac-
furin, and determination of the endocytic rate constant of Tac-furin
(Wiley and Cunningham, 1982) were performed using procedures de-
scribed previously (Ghosh et al., 1998).
To determine the exit rate of antibody-labeled Tac-furin from the cell,
TRVb-1/Tac-furin cells were incubated with FITC–anti-Tac for 60 min,
followed by a 30-min chase in McCoy’s/BSA. After this procedure, anti-
Tac is mostly detected in the TGN (see Fig. 3 D). Cells were further incu-
bated for 5, 10, 15, 20, 30, 40, 50, 60, 75, or 90 min in the presence of anti-
fluorescein antibodies (10 
 
m
 
g/ml) in the chase medium and fixed. We have
shown previously that antifluorescein antibodies are not internalized
by fluid-phase pinocytosis sufficiently to cause significant intracellular
quenching (Ghosh et al., 1998). Fluorescein fluorescence was imaged by
epifluorescence microscopy. Fluorescence power per cell was determined
as described below. Cells that did not receive antifluorescein exhibited in-
significant loss of fluorescence over the chase period (data not shown). To
determine if Tac-furin undergoes rapid endocytic recycling, TRVb-1/Tac-
furin cells were incubated with FITC-anti-Tac for 10 min, then washed in
medium and chased in the absence or presence of antifluorescein for 5, 10,
15, or 20 min. Cells were fixed, and fluorescein fluorescence was imaged
as described above.
 
Nocodazole and Wortmannin Studies
 
Experiments examining the effects of nocodazole and wortmannin on pro-
tein transport were performed in parallel. For all steps, BSA was omitted
from incubation media to prevent adsorption and deactivation of re-
agents, and all cells received 0.1% (vol/vol) DMSO to control for effects
of the solvent. Nocodazole-treated cells were pretreated with nocodazole
(33 
 
m
 
M) for 30 min at 4
 
8
 
C, then 30 min at 37
 
8
 
C. To maintain identical con-
ditions of temperature and DMSO exposure, wortmannin-treated cells
were incubated for 30 min at 4
 
8
 
C in the presence of 0.1% DMSO, then
pretreated with wortmannin (100 nM) for 30 min at 37
 
8
 
C. Untreated cells
were incubated for 30 min at 4
 
8
 
C and 30 min at 37
 
8
 
C in the presence of
0.1% DMSO. After pretreatments, cells were incubated with ligands for
15 min followed by a 45-min chase in the continuous presence of nocoda-
zole, wortmannin, or DMSO alone, respectively.
 
Image Processing and Quantification
 
Processing of digitized images was performed using the MetaMorph im-
age processing software package (Universal Imaging). All images were
corrected for background fluorescence and crossover between channels.
To quantify fluorescence power per cell (see Figs. 3, A and C, and 4 D),
the background fluorescence value was subtracted from images, and the
remaining fluorescence power in the field was summed and divided by the
number of cells in the field; typically, 10 fields of 
 
z
 
20 cells per field were
analyzed for each data point in a single experiment. For quantitative mi-
croscopic analyses and 
 
125
 
I-antibody experiments, data points were fit us-
ing the SigmaPlot software program (SPSS Inc.).
To quantify the colocalization of internalized fluorescent anti-Tac and
LDL over a time course, cells were imaged using the MRC600 confocal
microscope. Using routines available in the MetaMorph software pack-
age, images from the green and red channels were thresholded to detect
labeled objects above background fluorescence, then labeled endosomes
were selected on the basis of size (between 10 and 50 square pixels). Dou-
ble-labeled endosomes were identified by performing a logical AND op-
eration with the endosomes detected in the green and red channels. Inten-
sities of singly and doubly labeled endosomes were transferred to
Microsoft Excel for statistical analyses.
 
Results
 
Internalized Tac-Furin Is Delivered to the TGN
 
Tac-furin (TTF) was shown by Bonifacino and co-workers
to cycle between the plasma membrane and the TGN,
maintaining a steady-state enrichment in the TGN (Boss-
hart et al., 1994); similar behavior of exogenously ex-
pressed epitope-tagged furin was described by Thomas
and co-workers (Molloy et al., 1994). We transfected
TRVb-1 cells with the TTF form of Tac-furin and isolated
clonal populations expressing the chimeric construct (re-
ferred to as TRVb-1/TTF cells). Results presented here
were indistinguishable from those observed for two differ-
ent clones and for a polyclonal population; images and
data from a single clone are presented. At steady state, we
observed Tac-furin predominantly in the TGN, where it
colocalized with endogenous furin and with TGN38 (Fig.
1, A and B). The immunolocalized Tac-furin was not seen
in endosomes labeled with antibodies to the CI-MPR (Fig.
1 C) or with internalized dextrans (Fig. 1 D), indicating
that the expressed chimera is not detectable in endosomes
at steady state. We observed that the overlap of Tac-furin
and endogenous furin was incomplete (Fig. 1 A). This may
be due to the transport of a portion of endogenous furin
into the degradative pathway (Wolins et al., 1997). Alter-
natively, the two molecules may be partially distributed
into distinct subdomains of the TGN (Berger et al., 1995;
Ladinsky et al., 1999).
When TRVb-1/TTF cells were incubated with fluores-
cently labeled anti-Tac antibodies, the antibodies were in-
ternalized and transported over time to the TGN, which
was identified using anti-TGN38 antibodies (Fig. 2), using
antibodies against furin, or using the fluorescent lipid ana-
logue NBD-C
 
6
 
-ceramide (data not shown). Tac-furin was
detected in the TGN after 
 
z
 
30 min of internalization (Fig.
2, E and F), becoming further enriched there after 60 min
(Fig. 2, G and H). These results demonstrate the transport
of Tac-furin to the TGN in our system and confirm previ-
ous reports in other cell types. Internalized anti-Tac Fab
fragments were transported identically to intact IgG (data
not shown), demonstrating that our findings are not an ar-
tifact of protein aggregation by divalent IgG. The delivery
of internalized anti-Tac to the TGN in TRVb-1/TTF cells
allowed us to describe the kinetics of Tac-furin trafficking
by incubating cells with anti-Tac under various conditions.
 
Kinetic Parameters of Tac-Furin Transport
 
To determine the rate of exit of Tac-furin from TRVb-
1/TTF cells, the cells were incubated at 37
 
8
 
C with Cy3–
anti-Tac, and the cells were imaged by epifluorescence mi-
croscopy. The accumulation of the Cy3–anti-Tac was then
quantified in terms of fluorescence power per cell versus
incubation time (Fig. 3 A, solid line). Under these condi-
tions, the rate of accumulation of anti-Tac is equal to the
rate of appearance of unlabeled intracellular Tac-furin at
the plasma membrane (Ghosh et al., 1995). We found that
the antibody was accumulated by TRVb-1/TTF cells with
first-order kinetics, with a half-time of 
 
z
 
26 min (
 
k
 
 
 
5 
 
0.026
min
 
2
 
1
 
).
Alternatively, cells in a 24-well plate were incubated at
37
 
8
 
C for various times with 
 
125
 
I–anti-Tac antibodies, and 
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the cell-associated radioactivity was measured for each
time point. We found that the cells accumulated anti-Tac
with a half-time of 
 
z
 
36 min (
 
k
 
 
 
5 
 
0.019 min
 
2
 
1
 
) (Fig. 3 A,
dashed line). The difference in the exit rate constants ob-
tained from the two different methods is small compared
with other parameters of Tac-furin trafficking (see below),
and may be due to the differences in the experimental pro-
cedures. From the specific activity of the 
 
125
 
I–anti-Tac, the
asymptote of the accumulation curve, and the number of
cells in each well, we calculate that 
 
z
 
2 
 
3 
 
10
 
5
 
 copies of Tac-
furin are expressed per cell. Tac-furin and endogenous fu-
rin localize predominantly to the TGN in these cells (Fig. 1
and data not shown), so it is unlikely that sorting or reten-
tion mechanisms are saturated at this expression level.
To determine the steady-state surface expression of
Tac-furin, TRVb-1/TTF cells were incubated with 
 
125
 
I–
anti-Tac antibody at 0
 
8
 
C to prevent internalization, and
the bound counts were compared with the asymptote of
the 37
 
8
 
C 
 
125
 
I–anti-Tac accumulation curve. We estimate
that 5% of Tac-furin is at the plasma membrane at steady
state (data not shown).
We also measured the internalization rate constant of
Tac-furin in TRVb-1/TTF cells. As determined from the
ratios of internal to surface antibody over a brief time
course at 37
 
8
 
C, the protein is internalized with a rate con-
stant of 0.36 min
 
2
 
1
 
, which is consistent with the presence
of rapid internalization signals in the furin cytoplasmic
domain (Fig. 3 B). At steady state, the relative rates of in-
ternalization and externalization determine the relative
amounts of protein in internal compartments and at the
plasma membrane. The ratio of the measured rates of en-
docytosis (0.36 min
 
2
 
1
 
) and externalization (0.019 min
 
2
 
1
 
) of
 
125
 
I–anti-Tac is about 19, which agrees well with the esti-
mated internal-to-surface ratio of Tac-furin (also about
19). This indicates that our kinetic data accurately describe
the rates of trafficking of Tac-furin.
To demonstrate that antibody labeling did not perturb
the kinetics of Tac-furin trafficking, we measured the ex-
ternalization rate by another method. TRVb-1/TTF cells
were incubated for 60 min with FITC–anti-Tac, followed
by a 30-min chase. At this time, the FITC–anti-Tac pre-
dominantly labeled the TGN (Fig. 3 D). Subsequently, an-
tifluorescein was applied to the medium, and the cells
were incubated over a long time course to allow external-
Figure 1. Recombinantly ex-
pressed Tac-furin localizes to
the TGN at steady state. TRVb-
1/TTF cells were fixed in 4%
paraformaldehyde and perme-
abilized with 0.01% saponin in
Medium 1 with 0.5% (wt/vol)
BSA. Cells were incubated with
Cy3–anti-Tac (red) and poly-
clonal antibodies against furin
(green, A), TGN38 (green, B),
or CI-MPR (green, C) followed
by Alexa 488 goat anti–rabbit
secondary antibodies. In D, cells
were incubated with fluorescein-
conjugated dextrans (green) for
1 h before fixation, permeabili-
zation, and staining with Cy3–
anti-Tac (red). Z-series confo-
cal projections are shown. Pixels
labeled with both fluorophores
appear yellow. Bars, 10 mm.  
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ization of Tac-furin. Over this time period, the pericentri-
olar fluorescence signal decreased, indicating that the anti-
body was externalized from the TGN to the plasma
membrane (Fig. 3 E). Cells were then imaged by epifluo-
rescence microscopy, and the fluorescein fluorescence
power per cell was quantified for each time point (Fig. 3
C). The fluorescence power declined in a monoexponen-
tial fashion (
 
k
 
 
 
5 
 
0.026 min
 
2
 
1
 
), with a half-time of about 26
min indicating the rate of exit of FITC–anti-Tac–labeled
Tac-furin from the cells. This rate is similar to the rate of
externalization of unlabeled Tac-furin from cells (Fig. 3
A), confirming that antibody labeling has not altered the
kinetics of Tac-furin transport. Since the majority of the
FITC–anti-Tac was externalized from the TGN under this
procedure, the measured rate constant mainly reflects the
rate of transport of Tac-furin from the TGN to the plasma
membrane. The exact pathway and the rate of exit of Tac-
furin from the TGN per se are not directly shown by these
studies.
The agreement of this rate constant with that for whole-
cell antibody accumulation is consistent with the existence
of a single major exit route for Tac-furin (see below).
Also, the fluorescein quenching procedure measures only
the kinetics of externalization of the cycling Tac-furin
pool. Our results suggest either that the cycling and bio-
synthetic pools are externalized at the same rate or that
the contribution of the biosynthetic pool to these kinetics
is small. Finally, the transport of FITC–anti-Tac back to
the plasma membrane demonstrates that the antibody re-
mains associated with Tac-furin throughout its trafficking
itinerary. Otherwise, dissociated FITC–anti-Tac would ac-
cumulate in lysosomes, which was not observed. The low
level of residual fluorescence power observed in these ex-
periments after a prolonged chase is probably due to au-
tofluorescence and the incomplete quenching of fluo-
rescein by antifluorescein antibodies, as little TGN or
endosomal anti-Tac staining could be detected at the long-
est time points. The rapid internalization of Tac-furin at
the plasma membrane and the relatively slow movement
from the TGN to the plasma membrane account for the
steady-state localization of the chimera.
 
Tac-Furin Is Delivered to the TGN via Late Endosomes
 
We next determined the route by which Tac-furin is trans-
ported to the TGN. To evaluate if Tac-furin, like Tac-
TGN38, transits through the endocytic recycling pathway,
TRVb-1/TTF cells were incubated for 5 min with fluores-
cently-labeled anti-Tac and transferrin, then fixed immedi-
ately or chased in the continuous presence of transferrin to
label the recycling pathway (Fig. 4, A–C). As reported pre-
viously (Hopkins and Trowbridge, 1983; Yamashiro et al.,
1984), transferrin was detected primarily in the pericentri-
olar ERC and also in peripheral sorting endosomes. In
contrast, Tac-furin was observed in an exclusively punc-
tate distribution at early chase times (Fig. 4, A and B), ac-
cumulating in the TGN after a 40-min chase (Fig. 4 C). In
the absence of a chase, the two molecules partially colocal-
ized in sorting endosomes (data not shown), and the ex-
tent of colocalization declined rapidly with increasing
chase times. At no time was Tac-furin prominent in the
ERC, unlike Tac-TGN38 which is enriched in that or-
ganelle shortly after internalization (Ghosh et al., 1998).
We also found that endocytosed Tac-furin does not re-
cycle rapidly to the plasma membrane. TRVb-1/TTF cells
were incubated briefly with anti-Tac conjugated to fluo-
rescein (FITC–anti-Tac), then chased over a short time
course in the absence or presence of antifluorescein anti-
Figure 2. Accumulation of internalized Tac-furin in the TGN.
TRVb-1/TTF cells were incubated with Cy3–anti-Tac antibody
for 10 (A), 20 (C), 30 (E), or 60 min (G). Cells were fixed, perme-
abilized, and stained with anti-TGN38 polyclonal antibodies and
Alexa 488 goat anti–rabbit secondary antibodies (B, D, F, and
H). Z-series confocal projections are shown. Arrowheads in C
and D point to endosomes containing Tac-furin but not TGN38.
Arrows in G and H point to TGN elements labeled with both
probes. Bars, 10 mm. 
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bodies in the medium. Cells were imaged by epifluores-
cence microscopy, and the fluorescence power per cell was
determined for each chase time point (Fig. 4 D). If Tac-
furin is rapidly recycled, then the internalized FITC–anti-
Tac should reappear at the plasma membrane, where its
fluorescence would be quenched by the antifluorescein an-
tibodies. Instead, we observed no loss of cell-associated
fluorescence over the time of the chase. This finding again
contrasts with the rapid recycling of the bulk of internal-
ized Tac-TGN38, which was demonstrated using the same
approach (Ghosh et al., 1998).
The most common fate of an endocytosed protein that is
not recycled is accumulation in endosomes that over time
have matured and are segregated from the recycling path-
way. This class of endosomes is defined as late endosomes
(Dunn and Maxfield, 1992). For example, internalized
LDL dissociates from its receptor in sorting endosomes
and then is transported to late endosomes (Goldstein et al.,
1985; Dunn et al., 1989), where it no longer colocalizes
with internalized transferrin. Also, growth factor receptors
such as the epidermal growth factor receptor are trans-
ported to late endosomes and lysosomes after binding to
their corresponding ligands (Dunn et al., 1986; Miller et al.,
1986; Jackle et al., 1991). A population of late endosomes
is enriched in the CI-MPR (Willingham et al., 1983; Geuze
et al., 1984; Griffiths et al., 1988). To begin to characterize
the endosomal intermediate in Tac-furin trafficking, we in-
cubated TRVb-1/TTF cells for 5 min with anti-Tac anti-
body and chased for various times. Fluorescent transferrin
was applied during the last 5 min of the chase to label sort-
ing endosomes and the ERC. After fixation, the cells were
permeabilized and stained for the CI-MPR by indirect im-
munofluorescence (Fig. 5). At all time points, anti-Tac ex-
hibited a detectable but low degree of colocalization with
the CI-MPR (Fig. 5, A and B, and data not shown). In the
absence of chase, internalized anti-Tac colocalized with
transferrin in punctate sorting endosomes (data not
shown). This colocalization was lost with a chase, as anti-
Tac distributed into endosomes near the center of the cell
at 20 min (Fig. 5 C) and then eventually accumulated in
the TGN at 40 min (Fig. 5 D). Since the anti-Tac–labeled
endosomes observed at 20 min of chase do not contain
Figure 3. Kinetics of Tac-furin
transport. (A) TRVb-1/TTF
cells were incubated with anti-
Tac antibody conjugated to Cy3
(solid line) or 125I (dashed line)
for the indicated time course.
Cell-associated anti-Tac was
quantified as described in Mate-
rials and Methods and normal-
ized (asymptotes 5 100). Data
were fit to a first order rate
equation to obtain the accumu-
lation rate constants. Data
points represent the means of
two independent experiments;
error bars indicate standard er-
rors of the means. (B) Cells in
24-well plates were incubated
with  125I–anti-Tac for the indi-
cated times at 378C, then were rapidly shifted to 08C. Specific internal and surface-bound counts were determined, the ratios were
obtained for each sample, and the ratios were averaged among three wells each in four independent experiments. Means 6 SEM are
plotted. Data were fitted to a straight line to obtain the internalization rate constant for Tac-furin. (C) Cells were incubated with FITC–
anti-Tac to allow the antibody to accumulate in the TGN, then were incubated in the presence of antifluorescein antibodies for the indi-
cated times. Cell-associated fluorescence was calculated per cell as described in Materials and Methods. Means 6 SEM are plotted for
two independent experiments. Data were fitted to a monoexponential decay to obtain the externalization rate constant. (D) Represen-
tative field of cells labeled with fluorescein–anti-Tac as described in C and chased for 10 min in the presence of antifluorescein antibod-
ies. (E) Representative field after a 90-min chase in the presence of antifluorescein antibodies. The dim, hazy fluorescence is at the bor-
ders of the cells, and is not in a pattern resembling the TGN. Epifluorescence micrographs are shown. Bars, 10 mm. 
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transferrin, they are presumably matured endosomes that
have departed the recycling pathway.
The absence of Tac-furin from CI-MPR–enriched endo-
somes may be due to transport into a novel pathway dis-
tinct from the classical degradative pathway, or may be ex-
plained by the exit of Tac-furin from endosomes before
they have become significantly enriched in CI-MPR. The
existence of multiple classes of matured endosomes with
distinct properties has been reported in other systems
(Aniento et al., 1993; Gruenberg and Maxfield, 1995;
Kleijmeer et al., 1997). To establish the point at which a
molecule that follows the degradative pathway colocalizes
with the CI-MPR, fluorescent dextrans were followed
through a pulse-chase protocol over the same time course.
The dextrans were not enriched in CI-MPR–positive en-
dosomes until 40 min of chase (Fig. 5, E and F), at which
time anti-Tac had already accumulated in the TGN.
Therefore, transport of lysosomally targeted cargo into
CI-MPR–containing endosomes may occur after the time
of endosome maturation. This would allow a molecule
such as Tac-furin to enter newly formed late endosomes
and then exit before extensive delivery of the CI-MPR
into this compartment.
To confirm that endocytosed Tac-furin enters late endo-
somes, TRVb-1/TTF cells were pulsed for 5 min with fluo-
rescently labeled anti-Tac and LDL (Fig. 6). After a 5-min
chase, the two probes were detected in peripheral spots,
colocalizing significantly although incompletely (Fig. 6 A).
The frequency of double-labeled endosomes remained
high through about 15–20 min of chase (Fig. 6 B, yellow
spots). At these chase times, the majority of LDL is in late
endosomes (Salzman and Maxfield, 1989; Dunn and
Maxfield, 1992), segregated from recycling molecules such
as transferrin. Therefore, the colocalization of anti-Tac
with LDL demonstrates the transport of Tac-furin into
late endosomes. After a longer chase interval (Fig. 6 D),
anti-Tac no longer colocalized with LDL and was instead
found in a compartment resembling the TGN. When anti-
Tac and LDL were applied to cells with consecutive
pulses, such that one probe experienced a 20-min chase
and the other was not allowed a chase, the two probes did
not colocalize (data not shown). This result indicates that
the overlap of anti-Tac and LDL illustrated in Fig. 6 is not
in sorting endosomes that have not yet matured. Also,
anti-Tac rapidly lost colocalization with transferrin-con-
taining peripheral punctate sorting endosomes over this
time course (Figs. 4 and 5). Transport of internalized Tac-
furin through late endosomes en route to the TGN was
also demonstrated by colocalization in punctate structures
with internalized dextrans over a similar time course (data
not shown).
The extent of colocalization of anti-Tac and LDL was
quantified by two different computational methods. Endo-
somes labeled with LDL were selected, and the proportion
Figure 4. Internalized Tac-furin does not enter the endocytic recycling pathway.
(A–C) TRVb-1/TTF cells were incubated for 5 min with FITC–anti-Tac (green)
and Cy3-transferrin (red). Cells were chased for 5 (A), 10 (B), or 40 min (C) with
Cy3-transferrin before fixation. Single confocal slices are shown. Bars, 10 mm. (D)
Cells were incubated with FITC–anti-Tac for 10 min, then chased in the absence
(dashed line) or presence (solid line) of antifluorescein polyclonal antibodies for
the indicated times before fixation and epifluorescence imaging. Fluorescence in-
tensities per cell were calculated as described in Materials and Methods. Means 6
SEM for 10 fields of cells in a single experiment are shown. 
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that was also labeled with anti-Tac was quantified versus
chase time. Also, the ratio of anti-Tac to LDL fluores-
cence was measured for each double-labeled endosome,
and the distribution of these ratios was determined as a
function of chase time. These analyses were performed on
images similar to those in Fig. 6, using two independent
data sets. We found that the proportion of LDL-labeled
endosomes containing anti-Tac declined sharply between
20 and 40 min of chase, coincident with the appearance of
anti-Tac in the TGN (Fig. 7 A). In contrast, the population
of endosomes labeled with both probes exhibited no
change in fluorescence power ratios during this same in-
terval (Fig. 7 B), although the size of that population de-
creased over time. The abrupt loss of double-labeled en-
dosomes and the relative invariance of fluorescence power
ratios suggest that anti-Tac may be sorted away from LDL
by a highly concerted process, rather than by a more grad-
ual or iterative mechanism; in this way, a double-labeled
endosome would suddenly become singly labeled. We
failed to detect an accumulation of endosomes labeled
with anti-Tac and not with LDL, so it seems plausible that
Tac-furin follows a relatively direct route from endosomes
to the TGN. This event apparently precedes or coincides
with the delivery of CI-MPR to late endosomes from the
TGN, such that the two molecules mostly do not overlap.
 
The Transmembrane Domain of Furin Does Not 
Encode Essential Endosomal Sorting Information
 
In addition to cytoplasmic domain sorting signals, the
transmembrane domains of some membrane proteins
have been shown to perform a sorting function. In particu-
lar, the transmembrane domain of TGN38 has been shown
to play a role in the localization of that protein to the TGN
(Ponnambalam et al., 1994). To determine if the trans-
membrane domain of furin influences its postendocytic
trafficking, we expressed in TRVb-1 cells a construct en-
coding the ectodomain of Tac and the transmembrane and
cytoplasmic domains of furin (TFF) (Wolins et al., 1997).
We found that this chimeric protein, like TTF, was inter-
nalized and entered late endosomes, bypassing the recy-
cling pathway (data not shown). The internalized chimeras
entered the TGN over a similar time course, and the rates
of externalization from cells were almost identical for each
protein (
 
k
 
e
 
 
 
5 
 
0.023 min
 
2
 
1
 
 for TFF, and 0.025 min
 
2
 
1
 
 for
TTF in a single experiment). Therefore, the transmem-
brane domain appears not to be a major sorting determi-
nant of the endocytic transport of furin to the TGN. The
result is consistent with previous findings in other systems
(Bosshart et al., 1994; Wolins et al., 1997).
Figure 5. Internalized Tac-furin
is delivered to the TGN without
accumulation into CI-MPR–
labeled endosomes. (A–D)
TRVb-1/TTF cells were incu-
bated with Cy3–anti-Tac (red)
for 5 min and chased for 20 or 40
min as indicated. Cy5-transfer-
rin (Trfn, green in C and D) was
present for the last 5 min of the
chase. Cells were fixed, perme-
abilized, and labeled with poly-
clonal antibodies against CI-
MPR followed by Alexa 488
goat anti–rabbit secondary anti-
bodies (green in A and B). (E
and F) TRVb-1 cells were incu-
bated with rhodamine-dextrans
(red) for 5 min and chased for 20
or 40 min as indicated. Cells
were stained for CI-MPR
(green) as in A–D. Z-series con-
focal projections (A–D) and epi-
fluorescence micrographs (E
and F) are shown. Pixels labeled
with both fluorophores appear
yellow. Bars, 10 mm.  
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Transport Pathways of Tac-Furin and Tac-TGN38 to 
the TGN Are Differentially Sensitive to Nocodazole
and Wortmannin
 
The transport of Tac-furin to the TGN via late endosomes
is distinct from the pathway that is followed by Tac-
TGN38. The point at which the trafficking of the two
proteins diverges is the sorting endosome: Tac-furin is re-
tained as the sorting endosome matures into a late endo-
some, whereas Tac-TGN38 is transported to the ERC. To
show directly the divergent routes taken by these two chi-
meras, we performed a series of pulse-chase experiments
under conditions that are known to selectively alter differ-
ent properties of the endosomal system.
First, we took advantage of the effects of the microtu-
bule-disrupting compound, nocodazole. Nocodazole has
been shown to inhibit endosome maturation (Gruenberg
et al., 1989; Bomsel et al., 1990) but does not affect the ki-
netics of internalization or endocytic recycling (Sakai et al.,
1991; Takeuchi et al., 1992; Jin and Snider, 1993; McGraw
et al., 1993). We verified these effects in TRVb-1 cells ex-
pressing Tac-furin (TTF) or Tac-TGN38 (data not shown).
Therefore, treatment of cells with nocodazole provides a
means to discriminate between transport to the TGN via
late endosomes and transport via the recycling pathway.
TRVb-1/Tac-TGN38 and TRVb-1/TTF cells were pre-
treated with 33 
 
m
 
M nocodazole or 0.1% DMSO alone as
described in Materials and Methods. The cells were then
incubated with fluorescently labeled anti-Tac antibodies,
alone or in combination with fluorescent LDL for 15 min,
followed by a 45-min chase; nocodazole or DMSO was
Figure 6. Internalized Tac-furin
colocalizes with LDL in sorting
and then late endosomes en
route to the TGN. TRVb-1/TTF
cells were incubated for 5 min
with A488–anti-Tac (green) and
DiI-LDL (red), then chased for
5 (A), 15 (B), 30 (C), or 40 min
(D). Cells were fixed and im-
aged by confocal microscopy.
Z-series confocal projections are
shown. Pixels labeled with both
fluorophores appear yellow.
Bars, 10 mm.  
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present throughout this time course. After fixation, cells
that received anti-Tac alone were stained with NBD-C
 
6
 
-
ceramide to label the TGN. The distributions of the
probes were determined by confocal microscopy.
In TRVb-1/TTF cells treated with DMSO alone, inter-
nalized antibody colocalized well with NBD-C
 
6
 
-ceramide
(Fig. 8 A) and had very little overlap with LDL, which is
expected to label mainly late endosomes after this time
course (Fig. 8 B). However, nocodazole treatment re-
sulted in a substantial redistribution of anti-Tac into
LDL-containing structures, and overlap with NBD-C
 
6
 
-
ceramide was greatly diminished (Fig. 8, C and D). Note
the dispersion of the NBD-C
 
6
 
-ceramide staining, which is
a consequence of the fragmentation of the TGN caused
by microtubule disassembly (Rogalski and Singer, 1984;
Ladinsky and Howell, 1992). Since nocodazole inhibits
endosome maturation, we presume that anti-Tac and
LDL label sorting endosomes under these conditions. In
contrast, treatment of TRVb-1/Tac-TGN38 cells with no-
codazole had little effect on the transport of internalized
anti-Tac antibody to the TGN (Fig. 8 E), and the anti-
body exhibited limited overlap with internalized LDL
(Fig. 8 F). These results support the proposal that Tac-
furin is directed to the TGN by way of late endosomes,
whereas Tac-TGN38 travels via the endocytic recycling
pathway.
A second reagent having relevant effects on vesicular
transport is the phosphatidylinositol 3-OH kinase (PI3 ki-
nase) inhibitor wortmannin. Wortmannin exerts numerous
effects on endosomal trafficking, including the inhibition
of early endosome fusion (Jones and Clague, 1995; Li et al.,
1995; Spiro et al., 1996), the swelling of late endosomes
and impaired transport of hydrolases to lysosomes from
the TGN (Brown et al., 1995; Davidson, 1995), accelera-
tion of the rate of transferrin internalization (Martys et al.,
1996; Spiro et al., 1996), and a moderate slowing of en-
docytic recycling (Martys et al., 1996; Shpetner et al., 1996;
Spiro et al., 1996). However, wortmannin allows the deliv-
ery of internalized material to late endosomes (Martys
et al., 1996; Shpetner et al., 1996). These effects were also
observed in TRVb-1 cells expressing Tac-furin or Tac-
TGN38 (data not shown). Given these findings, we evalu-
ated whether or not wortmannin would affect the trans-
port of Tac-TGN38 or Tac-furin to the TGN from the
plasma membrane. TRVb-1/Tac-TGN38 and TRVb-1/TTF
cells were pretreated with 100 nM wortmannin or 0.1%
DMSO alone as described in Materials and Methods. The
cells were then incubated with fluorescently labeled anti-
Tac antibodies, alone or in combination with fluorescent
LDL for 15 min, then chased for 45 min in the presence or
absence of wortmannin. After fixation, cells that received
anti-Tac alone were stained with NBD-C
 
6
 
-ceramide to la-
bel the TGN. Samples that were not subjected to a chase
were also analyzed to verify the efficient internalization of
the probes irrespective of wortmannin treatment (data not
shown).
After 45-min chase, anti-Tac mostly labeled the TGN
in mock-treated cells, as observed previously (data not
shown). The trafficking of Tac-furin was severely inhibited
by wortmannin treatment. Under these conditions, inter-
Figure 7. Internalized Tac-furin abruptly exits LDL-labeled endosomes and is delivered to the TGN. Cells were incubated with A488–
anti-Tac and DiI-LDL as described for Fig. 5. (A) Endosomes labeled with LDL were selected. The proportion of those endosomes that
also labeled with anti-Tac was calculated for five fields for each time point. Data are plotted as mean percent colocalized 6 SEM. (B)
Endosomes labeled with both LDL and anti-Tac were identified, and the ratio of anti-Tac and LDL fluorescence powers was calculated
for each endosome. The common log of each ratio was calculated, and the population of ratios is plotted as a histogram for each time
point. The 10-, 20-, 30-, and 40-min histograms are shown. The Kruskal-Wallis analysis of variants indicates that these distributions are
not statistically different (P . 0.1). 
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nalized Tac-furin was delivered to the TGN only very inef-
ficiently, instead remaining colocalized with LDL (Fig. 9,
A–D). Note the nebulous appearance of the anti-Tac and
LDL labeling in Fig. 9, A, C, and D; this pattern is presum-
ably due to the effects of wortmannin on the morphology
of endosomes. The appearance of Tac-TGN38 in the TGN
also was reduced upon treatment with the drug, presum-
ably due to slower transit of the chimera through the en-
docytic recycling pathway. However, significant colocal-
ization of Cy3–anti-Tac and NBD-C
 
6
 
-ceramide was
apparent at the end of the 45-min chase (Fig. 9, E and F),
increasing with a more prolonged chase (data not shown).
Before delivery to the TGN, Tac-TGN38 remained colo-
calized with transferrin, and at no point was overlap with
internalized LDL observed (data not shown). Given the
reported activities of wortmannin and our own observa-
tions, the most straightforward conclusion is that Tac-furin
trafficking is blocked from late endosomes to the TGN.
This may represent a direct dependence of this transport
event on PI3-kinase activity, or may be an indirect conse-
quence of inhibiting the delivery of transport factors to
late endosomes. Irrespective of the precise point of action
of wortmannin, the absence of accumulation of Tac-
TGN38 in LDL-containing endosomes under these condi-
tions underscores the different pathways that these chime-
ras take in the endosomal system.
Figure 8. Nocodazole inhibits
the postendocytic transport of
Tac-furin to the TGN. TRVb-
1/Tac-furin (A–D) and Tac-
TGN38 (E and F) cells were
pretreated with 0.1% DMSO (A
and B) or 33 mM nocodazole in
DMSO (C–F) as described in
Materials and Methods. Cells
were then incubated for 15 min
with A488–anti-Tac (red; B, D,
and F) plus DiI-LDL (green; B,
D, and F) or Cy3–anti-Tac alone
(red; A, C, and E), followed by a
45-min chase, maintaining the
concentration of nocodazole
throughout. After fixation, cells
that received Cy3–anti-Tac were
stained with NBD-C6-ceramide
(green; A, C, and E). Z-series
confocal projections are shown.
Pixels labeled with both flu-
orophores appear yellow. Bars,
10 mm. 
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Discussion
 
Over the past several years, numerous reports have de-
scribed the transport of certain membrane-associated pro-
teins between the endosomal system and the secretory
pathway, specifically the TGN. However, the exact route
by which proteins are delivered to the TGN usually has
not been specified. This is significant since the transport
pathway determines where protein sorting must take place
and also may suggest the mechanism of sorting. We dem-
onstrated recently the postendocytic transport of a chi-
meric transmembrane protein, Tac-TGN38, to the TGN
via the endocytic recycling pathway (Ghosh et al., 1998).
In the present study, we have shown that another chimeric
protein which is localized to the TGN, Tac-furin, is deliv-
ered there from late endosomes and does not traverse the
recycling pathway. Therefore, CHO cells have at least two
distinct mechanisms for endocytic transport of membrane
proteins to the TGN (Fig. 10). Selective removal of Tac-
TGN38 from the recycling pathway apparently occurs
from the ERC. In contrast, Tac-furin is segregated from
recycling proteins at an earlier step, the sorting endosome,
 
allowing it to enter late endosomes. Furthermore, whereas
Tac-TGN38 is removed from the recycling pathway and
delivered to the TGN in an iterative manner, Tac-furin is
segregated from late endosomes by a more efficient, sin-
gle-pass mechanism, possibly in one concerted step.
The steady-state localization of a protein is determined
by the slowest step in its trafficking. Irrespective of the
transport itineraries and sorting mechanisms involved,
both Tac-furin and Tac-TGN38 are localized to the TGN
predominantly through their relatively slow rates of exit
from that compartment. This is likely reflected in the rates
of transport of the proteins from internal sites to the
plasma membrane, which are slower than all other kinetic
steps measured for each chimera. In the case of Tac-furin,
the kinetics of exit from the cell appears to be independent
of the transmembrane domain. However, this may not be
the case for Tac-TGN38 (Ponnambalam et al., 1994). Tac-
TGN38 exits the cell significantly slower than does Tac-
furin (Ghosh et al., 1998), implying a possible role of the
TGN38 transmembrane domain in retention of the chi-
mera in the TGN.
Figure 9. Wortmannin inhibits
the delivery of internalized Tac-
furin to the TGN, but has a
milder effect on Tac-TGN38
transport. TRVb-1/Tac-furin
(A–D) and Tac-TGN38 (E and
F) cells were pretreated with 100
nM wortmannin as described in
Materials and Methods. Cells
then were incubated for 15 min
with A488–anti-Tac (C) plus
DiI-LDL (D) or Cy3–anti-Tac
alone (A and E), followed by a
45-min chase, maintaining the
concentration of wortmannin
throughout. After fixation, cells
that received Cy3–anti-Tac were
stained with NBD-C6-ceramide
(Cer; B and F). Z-series confo-
cal projections are shown. Ar-
rows in C and D indicate some
points of colocalization to assist
the reader. Bars, 10 mm.Mallet and Maxfield Different Routes from the Plasma Membrane to the TGN 357
The two distinct endosomal pathways, which diverge at
the level of the sorting endosome, indicate at least two
sorting steps that are involved in transport to the TGN.
Tac-TGN38 traverses the recycling pathway that is fol-
lowed by the bulk of internalized membrane proteins in
CHO cells in the absence of specific targeting. From some
point along this pathway, Tac-TGN38 is then diverted for
delivery to the TGN. This process must require a specific
property of Tac-TGN38, such as an amino acid motif or se-
lective partitioning into membrane domains due to the
protein’s physical characteristics. The cytoplasmic domain
sequence, SDYQRL, appears to fulfill at least part of this
sorting function (Bos et al., 1993; Humphrey et al., 1993;
Wong and Hong, 1993; Ponnambalam et al., 1994). How-
ever, the SDYQRL motif is not sufficient for delivery
from the ERC to the TGN (Johnson et al., 1996). Addi-
tionally, the similarity of the trafficking itinerary of the
Shiga toxin B fragment, a soluble protein which binds to
the glycolipid globotriaosylceramide (Lingwood, 1993),
suggests that lipid-based sorting may also be critical along
this pathway (Mallard et al., 1998). We have not deter-
mined the point of departure of Tac-TGN38 from the re-
cycling pathway. The most likely possibility is that it exits
from the recycling compartment, although a direct path-
way from sorting endosomes cannot be excluded at
present.
The itinerary followed by Tac-furin is now more com-
pletely described. This protein evades the endocytic recy-
cling pathway, neither appearing in the ERC nor rapidly
returning to the plasma membrane. Rather, Tac-furin
transits from sorting endosomes to late endosomes, which
must require high-fidelity, active sorting of Tac-furin at
the sorting endosome. From late endosomes, Tac-furin is
transported to the TGN, apparently before the accumula-
tion of CI-MPR in late endosomes. This late endosome to
TGN step may also require active sorting, or this may be
the pathway taken by most membrane proteins that have
accessed late endosomes, in the absence of a positive sort-
ing signal. There is evidence that internalized membrane
proteins such as the transferrin and LDL receptors may be
transported from endosomes to the TGN at a low constitu-
tive rate (Snider and Rogers, 1985; Green and Kelly, 1992;
Bos et al., 1995). However, Tac-furin is delivered to the
TGN with much higher efficiency than those receptors.
Also, the transport of the cation-dependent mannose
6-phosphate receptor to the TGN requires an amino acid
sequence in its cytoplasmic domain, and the receptor is de-
graded in lysosomes if this signal is disrupted (Rohrer et al.,
1995). Whether dependent on a positive signal or not, the
kinetics of separation of Tac-furin from LDL indicate that
the mechanism for delivering Tac-furin to the TGN must
be able to segregate a membrane-associated molecule
from a soluble molecule very efficiently. This mechanism
must also allow the efficient transport of growth factor re-
ceptors from late endosomes to lysosomes and not to the
TGN. A series of reports has demonstrated the impor-
tance of an acidic cluster in the furin cytoplasmic domain
for its delivery to the TGN (Jones et al., 1995; Schäfer et al.,
1995; Takahashi et al., 1995; Voorhees et al., 1995), and
specifically, the phosphorylation of serine residues within
this region appears to be a major regulator of furin endo-
somal transport (Jones et al., 1995; Molloy et al., 1998),
possibly directing furin into a rapid recycling pathway. Ex-
tensive and detailed analyses will be required to determine
at which steps the acidic cluster, phosphorylation, and
other putative sorting signals are required.
The different endosomal pathways followed by Tac-
furin and Tac-TGN38 must require different sorting
mechanisms, as supported by studies using nocodazole and
wortmannin. The inhibition of Tac-furin transport by no-
codazole is readily explained, since the chimera is deliv-
ered via late endosomes, and entry of endocytosed pro-
teins into late endosomes is blocked by nocodazole. The
absence of an effect on Tac-TGN38 transport is consistent
with the properties of the endocytic recycling pathway, al-
though it would not necessarily be predicted that a route
linking the recycling pathway and the TGN would also be
independent of microtubules. Our data also suggest that
transport from late endosomes to the TGN depends on
PI3 kinase activity since wortmannin apparently causes in-
ternalized Tac-furin to accumulate in late endosomes
rather than in the TGN. This may reflect a general re-
quirement for PI3 kinase in late endosome to TGN traf-
ficking, or alternatively a specific role of PI3 kinase in the
pathway that transports furin. Analyses of the effects of
wortmannin treatment on endosome-to-TGN trafficking
in other systems have yielded conflicting results (Naka-
jima and Pfeffer, 1997; Kundra and Kornfeld, 1998).
An extensive series of studies by Thomas and co-work-
ers has revealed possible roles for a number of proteins,
Figure 10. Model for the transport of Tac-TGN38 and Tac-furin
from endosomes to the TGN. Both proteins are internalized from
the plasma membrane (PM) and initially enter sorting endo-
somes (SE). Tac-furin is then delivered to late endosomes (LE),
whereas Tac-TGN38 is transported to the ERC. The transport of
Tac-furin from late endosomes to the TGN occurs before or coin-
cident with the accumulation of CI-MPR in late endosomes (not
depicted). The exact route that Tac-TGN38 follows from the re-
cycling pathway to the TGN has not been determined, and may
be from the ERC or from sorting endosomes, as indicated by “?”
and the two converging arrows.The Journal of Cell Biology, Volume 146, 1999 358
including phosphofurin acidic cluster sorting protein 1
(PACS-1) (Wan et al., 1998), actin binding protein of 280
kD (Liu et al., 1997), and protein phosphatase 2A (Molloy
et al., 1998), at various stages of furin transport to modu-
late either delivery to or retention in the TGN. Specifi-
cally, PACS-1 interacts with the furin acidic domain.
PACS-1 also interacts with the MPR/IGF-II receptor but
not with the primate TGN38 homologue, TGN46 (Wan
et al., 1998), further supporting a role for PACS-1 in endo-
somal sorting. This interaction requires the phosphoryla-
tion of the furin cytoplasmic domain, which has also been
shown to be a modulator of the intracellular distribution
of furin (Jones et al., 1995; Molloy et al., 1998). The
TGN38 cytoplasmic domain can also be phosphorylated in
vitro with effects on its protein interactions (Zehavi-Fefer-
man et al., 1995), and like furin the endocytic transport of
TGN38 may be regulated by phosphorylation. However,
the factors that are responsible for TGN38 sorting after in-
ternalization have not been conclusively identified. These
may include as yet unidentified coat proteins and also may
involve Rab11 and/or other regulatory GTPases. Careful
examination of each step in endosomal transport will be
necessary to assign these various species to their respec-
tive sites of action.
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